TESK2 Human shRNA Lentiviral Particle (Locus ID 10420)

CAT#: TL320639V

TESK2 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

Product Images

GFP signal was observed under microscope at 48 hours after transduction of TL320639A virus into HEK293 cells. TL320639A virus was prepared using lenti-shRNA TL320639A and TR30037 packaging kit.

• 

  GFP signal was observed under microscope at 48 hours after transduction of TL320639B virus into HEK293 cells. TL320639B virus was prepared using lenti-shRNA TL320639B and TR30037 packaging kit.

• 

  GFP signal was observed under microscope at 48 hours after transduction of [TL320639C] virus into HEK293 cells. [TL320639C] virus was prepared using lenti-shRNA [TL320639C] and TR30037 packaging kit.

• 

  GFP signal was observed under microscope at 48 hours after transduction of [TL320639D] virus into HEK293 cells. [TL320639D] virus was prepared using lenti-shRNA [TL320639D] and TR30037 packaging kit.

Specifications

Product Data

• Locus ID: 10420
• Vector: pGFP-C-shLenti
• Format: Lentiviral particles
• RefSeq: NM_007170, NM_001320800, NM_007170.1, NM_007170.2, BC022194, BC033085, NM_007170.3
• UniProt ID: Q96S53
• Summary: This gene product is a serine/threonine protein kinase that contains an N-terminal protein kinase domain that is structurally similar to the kinase domains of testis-specific protein kinase-1 and the LIM motif-containing protein kinases (LIMKs). Its overall structure is most related to the former, indicating that it belongs to the TESK subgroup of the LIMK/TESK family of protein kinases. This gene is predominantly expressed in testis and prostate. The developmental expression pattern of the rat gene in testis suggests an important role for this gene in meitoic stages and/or early stages of spermiogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
• shRNA Design: These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
• Performance Guaranteed: OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples.
  
  For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).